Metastatic Hormone Refractory Prostate Cancer Active Not Recruiting Phase 2 Trials for Cediranib (DB04849)

Also known as: Metastatic hormone refractory Prostate cancer / Metastatic Prostate cancer / Prostate cancer metastatic / Metastatic Prostate Carcinoma / Carcinoma of the prostate metastatic / Prostatic cancer metastatic

IndicationStatusPhase
DBCOND0036371 (Metastatic Hormone Refractory Prostate Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02893917Olaparib With or Without Cediranib in Treating Patients With Metastatic Castration-Resistant Prostate CancerTreatment